Search

Author/Creator Beer, Tomasz

1. Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer. Issue 2 (December 2015)

Authors:
Beer, Tomasz; Vogelzang, Nicholas; Bartůňková, Jiřina; Miller, Kurt; Oh, William; Oudard, Stephane; Pandha, Hardev; Sartor, A; Špíšek, Radek; Toole, Timothy; Borgstein, Niels; Gerritsen, Winald
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma. Issue 1 (December 2016)

Authors:
McNeel, Douglas; Bander, Neil; Beer, Tomasz; Drake, Charles; Fong, Lawrence; Harrelson, Stacey; Kantoff, Philip; Madan, Ravi; Oh, William; Peace, David; Petrylak, Daniel; Porterfield, Hank; Sartor, Oliver; Shore, Neal; Slovin, Susan; Stein, Mark; Vieweg, Johannes; Gulley, James
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗